VLVbio and Euro Diagnostica enters manufacturing collaboration

Due to the increased demand and expanding interest for apoptosis markers, VLVbio has submitted their manufacturing to the trusted custom manufacturing partner Euro Diagnostica.

The growing demand for VLVbio‘s apoptosis markers has created a need for additional high quality manufacturing capacity. Since this trend is expected to prevail, it is crucial for VLVbio to have a partner that can adapt manufacturing volumes accordingly. “The partnership with Euro Diagnostica secures product availability now and in the future independently of how the demand will grow. The manufacturing transfer procedure deployed by Euro Diagnostica required only 165 days from first contact to product availability, according to VLVbio specifications” says Richard Herrmann, CEO VLVbio AB.